OSE Immunotherapeutics Stock
Stocks
OSE
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 3.318 EUR | -1.31% |
|
+3.17% | -35.57% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 78.04M 90.25M 73.4M 66.71M 125M 8.62B 127M 860M 336M 4.32B 339M 331M 14.39B | P/E 2026 * |
-2.55x | P/E 2027 * | -2.92x |
|---|---|---|---|---|---|
| Enterprise Value | 119M 137M 112M 102M 191M 13.12B 194M 1.31B 512M 6.58B 516M 505M 21.91B | EV / Sales 2026 * |
24.3x | EV / Sales 2027 * | 13.4x |
| Free-Float |
78.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | -1.31% | ||
| 1 week | +3.17% | ||
| Current month | +3.49% | ||
| 1 month | +0.67% | ||
| 3 months | -32.01% | ||
| 6 months | -23.97% | ||
| Current year | -35.57% |
| 1 week | 3.19 |  | 3.54 |
| 1 month | 3.13 | | 3.54 |
| Current year | 2.87 | | 5.9 |
| 1 year | 2.87 | | 7.7 |
| 3 years | 2.7 | | 11.58 |
| 5 years | 2.7 | | 13.68 |
| 10 years | 2.7 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 2025-10-01 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 2025-08-19 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 2016-05-30 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 2017-06-13 |
| Director/Board Member | - | 2023-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/13/24 | Sell | Director | 30,000 | 0.1375% | ||
| 11/12/24 | Sell | Chief Administrative Officer | 10,000 | 0.0458% | ||
| 6/21/24 | Fiscal year | Director | 10,000 | 0.0459% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31% | +3.17% | -48.24% | +18.92% | 91.23M | |
| -1.78% | -0.71% | +2.18% | +13.68% | 49.24B | |
| +0.85% | +2.98% | +464.76% | +579.26% | 43.3B | |
| -2.40% | +5.36% | +13.00% | +75.78% | 40.48B | |
| -2.01% | +1.82% | +24.41% | +7.65% | 39.75B | |
| -0.50% | +3.08% | +19.91% | +47.26% | 32.67B | |
| +0.38% | -1.08% | - | - | 16.23B | |
| -0.59% | -1.11% | +23.61% | +116.76% | 16.24B | |
| +0.49% | +0.80% | +5.45% | +22.29% | 14.04B | |
| -0.43% | +5.48% | +80.68% | +30.58% | 13.43B | |
| Average | -0.73% | +2.39% | +65.08% | +101.35% | 26.55B | |
| Weighted average by Cap. | -0.93% | +2.54% | +95.96% | +133.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.67M 4.61M 4.19M 7.86M 541M 8M 54.01M 21.1M 271M 21.28M 20.81M 903M | 10.53M 12.18M 9.9M 9M 16.9M 1.16B 17.19M 116M 45.35M 583M 45.72M 44.73M 1.94B |
| Net income | -30.59M -35.37M -28.77M -26.14M -49.09M -3.38B -49.94M -337M -132M -1.69B -133M -130M -5.64B | -21.47M -24.83M -20.19M -18.35M -34.45M -2.37B -35.05M -237M -92.46M -1.19B -93.22M -91.18M -3.96B |
| Net Debt | 40.79M 47.17M 38.37M 34.87M 65.47M 4.5B 66.6M 450M 176M 2.26B 177M 173M 7.52B | 63.08M 72.96M 59.33M 53.92M 101M 6.96B 103M 695M 272M 3.49B 274M 268M 11.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | €3.318 | -1.31% | 210,834 |
| 26-08-13 | €3.362 | +0.30% | 401,374 |
| 26-08-12 | €3.352 | +1.45% | 195,633 |
| 26-08-11 | €3.304 | +2.29% | 128,782 |
| 26-08-10 | €3.230 | -3.00% | 124,255 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
Select your edition
All financial news and data tailored to specific country editions
